FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Angelika Hellstern

Research Profile

Disorders

Concepts & Ideas

Chemicals & Drugs

Anatomy

Procedures

Phenomena

False Positive Reactions

Co-author Network

Publications

TOP 3
Marieta I Toma; Martin G Friedrich; Stefan H Hautmann; K Thorsten Jäkel; Andreas Erbersdobler; Angelika Hellstern; Hartwig Huland
Comparison of the ImmunoCyt test and urinary cytology with other urine tests in the detection and surveillance of bladder cancer.
Martin G Friedrich; M I Toma; Angelika Hellstern; Klaus Pantel; Daniel J Weisenberger; Joachim Noldus; Hartwig Huland
Comparison of multitarget fluorescence in situ hybridization in urine with other noninvasive tests for detecting bladder cancer.
Martin G Friedrich; Angelika Hellstern; Stefan H Hautmann; I Noldus; Hartwig Huland
[Non-invasive urine tests in diagnosis and as prognostic markers for urinary bladder carcinoma. Comparison of the BTAstat and NMP 22 tests with immunocytology using monoclonal antibodies against Lewis X and 486p3/12].

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Angelika Hellstern (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2004: Marieta I Toma; Martin G Friedrich; Stefan H Hautmann; K Thorsten Jäkel; Andreas Erbersdobler; Angelika Hellstern; Hartwig Huland
Comparison of the ImmunoCyt test and urinary cytology with other urine tests in the detection and surveillance of bladder cancer.
World journal of urology 2004;22(2):145-9.
2003: Martin G Friedrich; M I Toma; Angelika Hellstern; Klaus Pantel; Daniel J Weisenberger; Joachim Noldus; Hartwig Huland
Comparison of multitarget fluorescence in situ hybridization in urine with other noninvasive tests for detecting bladder cancer.
BJU international 2003;92(9):911-4.
2003: Martin G Friedrich; Angelika Hellstern; Stefan H Hautmann; I Noldus; Hartwig Huland
[Non-invasive urine tests in diagnosis and as prognostic markers for urinary bladder carcinoma. Comparison of the BTAstat and NMP 22 tests with immunocytology using monoclonal antibodies against Lewis X and 486p3/12].
Der Urologe. Ausg. A 2003;42(4):523-30.
2003: Martin G Friedrich; Angelika Hellstern; Marieta I Toma; Peter Hammerer; Hartwig Huland
Are false-positive urine markers for the detection of bladder carcinoma really wrong or do they predict tumor recurrence?
European urology 2003;43(2):146-50; discussion 150-1.
2002: Martin G Friedrich; Angelika Hellstern; Stefan H Hautmann; Markus Graefen; Stefan Conrad; Edith Huland; Hartwig Huland
Clinical use of urinary markers for the detection and prognosis of bladder carcinoma: a comparison of immunocytology with monoclonal antibodies against Lewis X and 486p3/12 with the BTA STAT and NMP22 tests.
The Journal of urology 2002;168(2):470-4.
2001: Stefan H Hautmann; Grethchen L Schroeder; Francisco Civantos; Robert Duncan; R Gnann; Martin G Friedrich; Angelika Hellstern; Hartwig Huland; Mark S Soloway; Vinata B Lokeshwar
[Hyaluronic acid and hyaluronidase. 2 new bladder carcinoma markers].
Der Urologe. Ausg. A 2001;40(2):121-6.